噻托溴铵在慢性阻塞性肺疾病中的应用进展被引量：1

Applications and advancements of tiotropium bromide in treatment of chronic obstructive pulmonary disease

导出

摘要支气管扩张剂可减轻气流受限，被认为是改善慢性阻塞性肺疾病（chronic obstructive pulmonary disease，COPD）症状的主要治疗药物。目前随着药物研究的发展，长效抗胆碱能药物——噻托溴铵在COPD治疗中发挥了重要的作用。它能改善COPD患者肺功能，与其它支气管扩张剂疗效比较具有明显的优势，同时联合两种或两种以上其它不同作用机制的支气管扩张剂可增加支气管扩张程度而不增加不良反应，故被认为是COPD维持治疗的一线药物之一。 Knowned as chief curatives to improve symptoms of chronic obstructive pulmonary disease （COPD）, bronchodilators can relieve airflow limitation. Nowadays, along with the developments of pharmacal investigation, long acting anticholinergic drug-tiotropium bromide plays an important role in the treatment of COPD. It can improve the lung function of COPD, has evident ascendancies in curative effect in comparing with other bronchodilators,can increase bronchiectasic extent but do not augment adverse effect in combinateing two or varied different bronchodilators in its mechanism. Therefore,it is knowned as one of the first-line drugs in the rnaintenane therapy.

作者张彩霞杨炯

机构地区武汉大学人民医院呼吸内科

出处《国际呼吸杂志》 2008年第7期433-435,共3页 International Journal of Respiration

关键词慢性阻塞性肺疾病抗胆碱能药物噻托溴铵支气管扩张剂 Chronic obstructive pulmonary disease Anticholinergic drug

分类号 R563.9 [医药卫生—呼吸系统]

引文网络
相关文献

参考文献16

1Barnes PJ. New developments in anticholinergic drugs. Eur Respir Rev, 1996,6:290-294.
2Disse B, Reichl R,Speck G, et al. BA 679 BR, a novel long-acting antimuscarinic bronchodilator. Life Sci, 1993,52 : 537-544.
3Casaburi R, Briggs DD Jr, Donohue JF, et al. The spirometrie efficacy of once-daily dosing with tiotropium in stable COPD: a 13-week multicenter trial. The US Tiotropium Study Group. Chest, 2000,118 : 1294-1302.
4Littner MR, Ilowite JS, Tashkin DP, et al. Long-aeting bronehodilation with onee-daily dosing of tiotropium(Spiriva) in stable ehronie obstruetive pulmonary disease. Am J Respir Crit Care Med,2000,161(4 Pt 1):1136-1142.
5Pellegrino R, Brusasco V. Lung hyperinflation and flow limitation in chronic airway obstruction. Eur Respir J, 1997,10 543-549.
6Nigro CA, Prieto JE, Kleinert MM, et al. Effect of inhaled salbutamol on dynamic intrinsic positive end-expiratory pressure in spontaneously breathing patients with stable severe chronic obstructive pulmonary disease. Med Sci Monit, 2005, 11 : PI81- 85.
7Celli B, ZuWallaek R, Wang S, et al. Improvement in testing inspiratory capacity and hyperinflation with tiotropium in COPD patients with increased lung volumes. Chest, 2003, 124: 1743- 1748.
8O'Donnell CE,Lam M,Webb KA. Measurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 1998,158(5 Pt 1):1557-1565.
9O'Donnell DE,Fluge T,Gerken F,et al. Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Eur Respir J, 2004,23 : 832-840.
10Briggs DD Jr, Covelli H, Lapidus R, et al. Improved daytime spirometric efficacy of tiotropium compared with salmeterol in patients wit h COPD. Pulm Pharmacol Ther, 2005,18 : 397-404.